BIRB796, an Inhibitor of p38 Mitogen-Activated Protein Kinase, Inhibits Proliferation and Invasion in Glioblastoma Cells

Slični predmeti

• BIRB796, an Inhibitor of p38 Mitogen-Activated Protein Kinase, Inhibits Proliferation and Invasion in Glioblastoma Cells
  od: Linyao Zhao, i dr.
  Izdano: (2021-04-01)
• Combining inotuzumab ozogamicin with the p38 inhibitor BIRB 796 and venetoclax exerts synergistic cytotoxicity in B-cell precursor acute lymphoblastic leukemia including very high risk t(17;19) acute lymphoblastic leukemia
  od: Lisa Fleischer, i dr.
  Izdano: (2026-06-01)
• Multiple transport-active binding sites are available for a single substrate on human P-glycoprotein (ABCB1).
  od: Eduardo E Chufan, i dr.
  Izdano: (2013-01-01)
• Antimicrobial Peptide Reverses ABCB1-Mediated Chemotherapeutic Drug Resistance
  od: Xiaofang Luo, i dr.
  Izdano: (2020-08-01)
• Ceritinib Enhances the Efficacy of Substrate Chemotherapeutic Agent in Human ABCB1-Overexpressing Leukemia Cells In Vitro, In Vivo and Ex-Vivo
  od: Li Yang, i dr.
  Izdano: (2018-05-01)